Scopus BioPharma Inc.'s former CEO and chief financial officer sued members of its board in Delaware over claims that they helped affiliates of HCFP/Capital Markets LLC “pillage the company” by funneling millions to themselves.
The derivative lawsuit, made public Monday, accuses Scopus board members linked to HCFP of exploiting their control over the company “to extract as much money for themselves as possible” while wasting “large sums of the company’s money to shield themselves from oversight.”
Those self-serving expenses include stealing 3.5 million shares from the ex-CEO and bringing in high-powered attorneys from Boies Schiller Flexner LLP “as their personal ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.